Shandong Buchang Pharmaceuticals Co Ltd603858
▲ ポジティブ技術関連度
Subsidiary signs contracts to develop two Class III medical devices, expanding product pipeline.
銘柄への影響 1
その他
Shandong Buchang Pharmaceuticals Co Ltdテーマインパクト
カバレッジ外企業 2
Baoding Tianhao Biotechnology Co., Ltd.非上場▲ ポジティブ
技術関連度
As the subsidiary, it directly commissions R&D for two new injectable fillers, gaining IP and revenue rights.
Beijing Xinliyan非上場▲ ポジティブ
需要関連度
Receives technology development contracts, generating revenue from R&D services and future manufacturing.